Daily non-political popular news in brief.

New chemistry approach promises less expensive drugs

With a newly discovered method of assembling organic molecules, chemists may have found a way to sidestep many of the expensive and hazardous barriers that stand in the way of drug development. The new approach allows scientists to synthesize molecules without employing toxic catalysts, and it also does not generate alternate versions of drug molecules that can damage the body, two perennial issues that plague the manufacturing process.

Read more »

Keywords: chemistry, approach, promises, expensive, drugs, promise, drug

« Previous | Next »

Similar news on "New chemistry approach promises less expensive drugs":

1. Drug eluting nanostructured coatings enable targeted drug therapy for orthopedic patients
   05-20-2007 · EurekAlert!
   Drug delivery systems have progressed from the teaspoon to time-release capsules to drug-eluting stents. Nanotechnology promises yet another advance by delivering therapeutic agents at desired rates exactly where needed in the body. In a paper presented at the NSTI Nanotech 2007 Conference, researchers at the University of California, San Francisco demonstrate how they have created nanotubes from biocompatible metal oxides that can hold therapeutic proteins or drugs and deliver these agents in a highly-controlled manner.
   Similar news · Read more »
   
2. Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs
   09-29-2006 · ScienceDaily
   In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."
   Similar news · Read more »
   
3. Using green chemistry to deliver cutting-edge drugs
   09-13-2007 · EurekAlert!
   Green chemistry is being employed to develop revolutionary drug delivery methods that are more effective and less toxic -- and could benefit millions of patients.
   Similar news · Read more »
   
4. Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
   11-28-2007 · EurekAlert!
   Sirtris Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced today that findings in the journal Nature demonstrate that Sirtris has developed novel drug candidates that offer a promising, new approach to treating diseases of aging, including type 2 diabetes, by targeting SIRT1, a gene that controls the aging process.
   Similar news · Read more »
   
5. Tequila raw ingredient being developed into drug-carrier that targets colon diseases
   03-27-2007 · EurekAlert!
   Compounds derived from the blue agave, a fruit used to make tequila, show promise as a natural, more effective way to deliver drugs to the colon than conventional drug-carriers, according to chemists at the University of Guadalajara in Mexico. The discovery could lead to improved treatments for a variety of colon diseases, including ulcerative colitis, irritable bowel and cancer, they say. The research will be presented in March at the American Chemical Society national meeting.
   Similar news · Read more »
   
6. Unusually stable glasses may benefit drugs, coatings
   12-08-2006 · EurekAlert!
   A new approach to making remarkably stable glassy materials from organic molecules, developed by researchers from the University of Wisconsin-Madison and the NIST Center for Neutron Research, could lead to novel coatings and to improvements in drug delivery.
   Similar news · Read more »
   
7. Assembling the jigsaw puzzle of drug addiction
   01-04-2008 · EurekAlert!
   Using an integrative meta-analysis approach, researchers from the Center for Bioinformatics at Peking University in Beijing have assembled the most comprehensive gene atlas underlying drug addiction and identified five molecular pathways common to four different addictive drugs. This novel paper appears in PLoS Computational Biology on Jan. 4, 2008.
   Similar news · Read more »
   
8. New drug combination shows promise for African sleeping sickness
   11-06-2007 · EurekAlert!
   A small clinical trial in Uganda, conducted within a long-established Medecins Sans Frontieres treatment program for African sleeping sickness, has found that a new combination treatment using the drugs nifurtimox and eflornithine holds promise and deserves further evaluation. Despite the low sample size, the findings were promising: no cases of treatment failure, no treatment terminations, and no HAT- or treatment-related deaths.
   Similar news · Read more »
   
9. Study: Re-engineered Gleevec reduces heart risks
   12-03-2007 · EurekAlert!
   Using a new bottom-up approach for rational drug design, researchers at Rice University and the University of Texas M. D. Anderson Cancer Center have reengineered the powerful anticancer drug imatinib -- best known by its brand name Gleevec -- to more specifically target one type of cancer while potentially curbing a rare life-threatening cardiotoxic side effect. The re-design strategy employed in the study is broadly applicable to reducing side effects in other drugs.
   Similar news · Read more »
   
10. Developing a modular, nanoparticle drug delivery system
    10-05-2007 · EurekAlert!
    With the support from a $478,000, five-year CAREER award from the National Science Foundation, chemist Eva Harth is creating a modular, multi-functional drug delivery system that promises simultaneously to enhance the effectiveness and reduce undesirable side-effects of a number of different drugs.
    Similar news · Read more »